Mitochondrial-Derived Peptides In Female Reproduction: Emerging Regulators Of Oocyte Competence And Novel Therapeutic Opportunities For Infertility
Our bodies are made of tiny cells, and within these cells are even tinier powerhouses called mitochondria. These mitochondria don’t just produce energy; they also create special small proteins called mitochondrial-derived peptides (MDPs). Recent research highlights the critical role these MDPs play in female reproduction, particularly in the health and developmental potential of egg cells, a concept known as oocyte competence.
These tiny peptides, including MOTS-c, Humanin, and SHLP2, are vital for maintaining healthy cellular metabolism (the chemical processes that keep cells alive), managing oxidative stress (an imbalance that can damage cells), and regulating apoptosis (the body’s natural process of programmed cell death). Interestingly, the levels of these important MDPs tend to decrease as we age, which mirrors the natural decline in egg cell quality over time. Studies have also shown reduced levels of MOTS-c in conditions like polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome (PCOS), a common hormonal disorder affecting women.
The findings suggest that understanding and potentially manipulating these MDPs could open up exciting new possibilities for treating infertility. They are being explored as potential biomarkers to assess egg cell quality and as novel therapeutic targets in assisted reproductive technology (ART), such as in vitro fertilization (IVF), to improve outcomes. By promoting energy production, reducing cellular stress, and stabilizing mitochondrial membranes, these peptides could help enhance egg cell quality and support the growth of follicles, ultimately boosting female fertility.
Source: link to paper